Clinical Reviews in Allergy & Immunology

, Volume 39, Issue 3, pp 176–184 | Cite as

The Role of NK Cells in the Autoimmune Thyroid Disease-associated Pregnancy Loss

Article

Abstract

Pregnancy loss is a frequent event. Autoimmune thyroid disorders and altered natural killer (NK) cell functions are two distinct risk factors, which independently could induce adverse pregnancy outcome. Thyroid autoimmunity has been an object of increased attention by investigators in the context of pregnancy loss. Peripheral NK cells and uNK cells comprise distinct cell populations in terms of phenotype and function but they play an important role in the course of a normal human pregnancy via several potential functions. In autoimmune thyroid diseases, several abnormalities of killer cell activity have been described. The functional defects involving NK maturation and/or functional activation observed in Graves’ disease patients could independently influence the reproductive outcome. This suggestion needs extensive investigation and could be important for the therapeutical approach in preventing pregnancy loss in patients with thyroid autoimmunity.

Keywords

Pregnancy loss Thyroid autoimmunity Natural killer cells 

References

  1. 1.
    Еdmonds DK, Lindsay KI, Miller JF (1982) Early embryonic mortality in women. Fertil Steril 38:447–453Google Scholar
  2. 2.
    Baines MG, Gendron RL (1993) Natural and experimental animal models of reproductive faiture. In: Chaouat G (ed) Immunology of pregnancy. CRC Press, Boca Raton, pp 173–203Google Scholar
  3. 3.
    Alberman E (1988) The epidemiology of repeated abortion. In: Beard RW, Sharp F (eds) Early pregnancy loss: mechanisms and treatment. Springer-Verlag, New York, pp 9–17Google Scholar
  4. 4.
    Daya S (2002) Habitual abortion. In: Copeland LJ, Jarell JF (eds) Textbook of gynecology, 2nd edn. W.B. Saunders, Philadelphia, pp 227–271Google Scholar
  5. 5.
    World Health Organization (1977) Recommended definition, terminology and format for statistical tables related to the perinatal period. Acta Obstet Gynecol Scand 56:247–253Google Scholar
  6. 6.
    Reiss HE (1998) Reproductive medicine: from A to Z. Oxford University Press, OxfordGoogle Scholar
  7. 7.
    Li TC, Makris M, Tomsu M, Tuckerman EM, Laird SM (2002) Recurrent miscarriage, aetiology, management and prognosis. Hum Reprod Update 8:463–481PubMedGoogle Scholar
  8. 8.
    Regan L, Rai R (2000) Epidemiology and the medical cause of miscarriage. Bailliere’s Clin Obstet Gynaecol 14:839–854Google Scholar
  9. 9.
    Clifford K, Rai R, Watson H, Regan L (1994) An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 7:1328–1332Google Scholar
  10. 10.
    Katz VL, Kuller JA (1994) Recurrent miscarriage. Am J Perinatol 11:386–397PubMedGoogle Scholar
  11. 11.
    Stagnaro-Green A, Roman SH, Cobin RH et al (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264:1422–1425PubMedGoogle Scholar
  12. 12.
    Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N (1993) Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 168:837–841PubMedGoogle Scholar
  13. 13.
    Bussen S, Steck T (1995) Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions. Hum Reprod 10:2938–2940PubMedGoogle Scholar
  14. 14.
    Bussen SS, Steck T (1997) Thyroid antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters). Eur J Obstet Gynecol Reprod Biol 74:139–143PubMedGoogle Scholar
  15. 15.
    Esplin MS, Branch DW, Silver R, Stagnaro-Green A (1998) Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 179:1583–1586PubMedGoogle Scholar
  16. 16.
    Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT Jr (1999) Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 71:843–848PubMedGoogle Scholar
  17. 17.
    Dendrinos S, Papasteriades C, Tarassi K, Christodoulakos G, Prasinos G, Creatsas G (2000) Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 14:270–274PubMedGoogle Scholar
  18. 18.
    Mecacci F, Parretti E, Cioni R et al (2000) Thyroid autoimmunity and its association with non-organ-specific antibodies and subclinical alterations of thyroid function in women with a history of pregnancy loss or preeclampsia. J Reprod Immunol 46:39–50PubMedGoogle Scholar
  19. 19.
    Bagis T, Gokcel A, Saygili ES (2001) Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid 11:1049–1053PubMedGoogle Scholar
  20. 20.
    Glinoer D, Soto MF, Bourdoux P et al (1991) Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 73:421–427PubMedGoogle Scholar
  21. 21.
    Pratt DE, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N (1993) The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril 60:1001–1005PubMedGoogle Scholar
  22. 22.
    Lejeune B, Grun JP, de Nayer P, Servais G, Glinoer D (1993) Antithyroid antibodies underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension. Br J Obstet Gynaecol 100:669–672PubMedGoogle Scholar
  23. 23.
    Singh A, Dantas ZN, Stone SC, Asch RH (1995) Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril 63:277–281PubMedGoogle Scholar
  24. 24.
    Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N (1997) Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 90:364–369PubMedGoogle Scholar
  25. 25.
    Kim CH, Chae HD, Kang BM, Chang YS (1998) Influence of antithyroid antibodies in euthyroid women on in vitro fertilization-embryo transfer outcome. Am J Reprod Immunol 40:2–8PubMedGoogle Scholar
  26. 26.
    Muller AF, Verhoeff A, Mantel MJ, Berghout A (1999) Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Fertil Steril 71:30–34PubMedGoogle Scholar
  27. 27.
    Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N, Regan L (2000) Prospective pregnancy outcome in untreated recurrent miscarries with thyroid autoantibodies. Hum Reprod 15:1637–1639PubMedGoogle Scholar
  28. 28.
    Poppe K, Glinoer D, Tournaye H et al (2003) Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab 88:4149–4252PubMedGoogle Scholar
  29. 29.
    Prummel MF, Wiersinga WM (2004) Thyroid autoimmunity and miscarriage. Eur J Endocrinol 150:751–755PubMedGoogle Scholar
  30. 30.
    Sandercock P (1989) The odds ratio: a useful tool in neurosciences. J Neurol Neurosurg Psychiatry 52:817–820PubMedGoogle Scholar
  31. 31.
    Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M (2008) Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract 14:458–464PubMedGoogle Scholar
  32. 32.
    Bellver J, Soares SR, Alvarez C et al (2008) The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod 23:278–284PubMedGoogle Scholar
  33. 33.
    Kilic S, Tasdemir N, Yilmaz N, Yuksel B, Gul A, Batioglu S (2008) The effect of anti-thyroid antibodies on endometrial volume, embryo grade and IVF outcome. Gynecol Endocrinol 24:649–655PubMedGoogle Scholar
  34. 34.
    Stuart AE (1994) Autoantibodies and pregnancy loss. Lancet 343:747–748Google Scholar
  35. 35.
    Glinoer D (1997) The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18:404–433PubMedGoogle Scholar
  36. 36.
    Matalon ST, Blank M, Ornoy A, Shoenfeld Y (2001) The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol 45:72–77PubMedGoogle Scholar
  37. 37.
    Lazarus JH, Kokandi A (2000) Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol 53:265–278Google Scholar
  38. 38.
    Menken J, Trussell J, Larsen U (1986) Age and infertility. Science 233:1389–1394PubMedGoogle Scholar
  39. 39.
    Matalon ST, Blank M, Levy Y et al (2003) The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod 18:1094–1099PubMedGoogle Scholar
  40. 40.
    Lee YL, Ng HP, Lau KS et al (2008) Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertil Steril 91(5 Suppl):2104–2109PubMedGoogle Scholar
  41. 41.
    Wilson R et al (1999) Thyroid antibody titer and avidity in patients with recurrent miscarriage. Fertil Steril 71:558–561PubMedGoogle Scholar
  42. 42.
    Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76:2421–2438PubMedGoogle Scholar
  43. 43.
    Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer cell subsets. Trends Immunol 22:633–640PubMedGoogle Scholar
  44. 44.
    Naume B, Johnsen AC, Espevik T, Sundan A (1993) Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol 23:1831–1838PubMedGoogle Scholar
  45. 45.
    Biassoni R, Ferrini S, Prigione I, Pelak VS, Sekaly RP, Long EO (1991) Activated CD3-CD16+ natural killer cells express a subset of the lymphokine genes induced in activated αß + and γδ + T cells. Scand J Immunol 33:247–252PubMedGoogle Scholar
  46. 46.
    King A, Allan DS, Bowen M et al (2000) HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 30:1623–1631PubMedGoogle Scholar
  47. 47.
    Lanier LL (2001) On guard—activating NK cell receptors. Nat Immunol 2:23–27PubMedGoogle Scholar
  48. 48.
    Gregory CD, Lee H, Rees GB, Scott IV, Shah LP, Golding PR (1985) Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays. Clin Exp Immunol 62:121–127PubMedGoogle Scholar
  49. 49.
    Gregory CD, Lee H, Scott IV, Golding PR (1987) Phenotypic heterogeneity and recycling capacity of natural killer cells in normal human pregnancy. J Reprod Immunol 11:135–145PubMedGoogle Scholar
  50. 50.
    Ponte M et al (1999) Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 96:5674–5679PubMedGoogle Scholar
  51. 51.
    King A (2000) Uterine leukocytes and decidualization. Hum Reprod Update 6:28–36PubMedGoogle Scholar
  52. 52.
    Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW (1994) Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 153:4427–4435PubMedGoogle Scholar
  53. 53.
    Saito S et al (1993) Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int Immunol 5:559–563PubMedGoogle Scholar
  54. 54.
    Koopman LA et al (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198:1201–1212PubMedGoogle Scholar
  55. 55.
    Croy BA, Chapeau C (1990) Evaluation of the pregnancy immunotrophism hypothesis by assessment of the reproductive performance of young adult mice of genotype scid/scid.bg/bg. J Reprod Fertil 88:231–239PubMedGoogle Scholar
  56. 56.
    Curran EM, Berghaus LJ, Vernetti NJ, Saporita AJ, Lubahn DB, Estes DM (2001) Natural killer cells express estrogen receptor- and estrogen receptor-ß and can respond to estrogen via a non-estrogen receptor-α-mediated pathway. Cell Immunol 214:12–20PubMedGoogle Scholar
  57. 57.
    Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO (2003) Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 88:440–449PubMedGoogle Scholar
  58. 58.
    Ehring GR et al (1998) A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K + channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med 188:1593–1602PubMedGoogle Scholar
  59. 59.
    Inoue T et al (1996) Progesterone stimulates the induction of human endometrial CD56+ lymphocytes in an in vitro culture system. J Clin Endocrinol Metab 81:1502–1507PubMedGoogle Scholar
  60. 60.
    Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E (2002) Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23:401–430PubMedGoogle Scholar
  61. 61.
    Verma S, Hiby SE, Loke YW, King A (2000) Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 62:959–968PubMedGoogle Scholar
  62. 62.
    Kitaya K, Nakayama T, Okubo T, Kuroboshi H, Fushiki S, Honjo H (2003) Expression of macrophage inflammatory protein-1ß in human endometrium: its role in endometrial recruitment of natural killer cells. J Clin Endocrinol Metab 88:1809–1814PubMedGoogle Scholar
  63. 63.
    Ntrivalas EI et al (2001) Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 16:855–861PubMedGoogle Scholar
  64. 64.
    Aoki K et al (1995) Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 345:1340–1342PubMedGoogle Scholar
  65. 65.
    Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I (2000) Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 15:1163–1169PubMedGoogle Scholar
  66. 66.
    Shimada S et al (2004) No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 19:1018–1024PubMedGoogle Scholar
  67. 67.
    Lachapelle MH, Miron P, Hemmings R, Roy DC (1996) Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 156:4027–4034PubMedGoogle Scholar
  68. 68.
    Clifford K, Flanagan AM, Regan L (1999) Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 14:2727–2730PubMedGoogle Scholar
  69. 69.
    Quenby S et al (1999) Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 14:2386–2391PubMedGoogle Scholar
  70. 70.
    Michimata T et al (2002) Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 47:196–202PubMedGoogle Scholar
  71. 71.
    Trinchieri G, Kobayashi M, Seehra J, London L, Perussia B (1984) Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 160:1147–1169PubMedGoogle Scholar
  72. 72.
    Baxter AG, Smyth MJ (2002) The role of NK cells in autoimmune disease. Autoimmunity 35:1–14PubMedGoogle Scholar
  73. 73.
    Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG (2002) The natural killer cell—friend or foe in autoimmune disease? Scand J Immunol 55:432–441PubMedGoogle Scholar
  74. 74.
    Hauser SL, Ault US, Levin MJ, Garovoy MR, Weiner HL (1981) Natural killer cell activity in multiple sclerosis. J Immunol 127:1114–1117PubMedGoogle Scholar
  75. 75.
    Auer IO, Ziemer E, Sommer H (1980) Immune status in Crohn’s disease. Clin Exp Immunol 42:41–47PubMedGoogle Scholar
  76. 76.
    Goto M, Tanimoto K, Chihara T, Horiuchi Y (1981) Natural cell-mediated cytotoxicity in Sjogren’s syndrome and rheumatoid arthritis. Arthritis Rheum 24:1377–1382PubMedGoogle Scholar
  77. 77.
    Yabuhara A et al (1996) A killing defect of natural killer cells as an underlying immunological abnormality in childhood systemic lupus erythematosus. J Rheumatol 23:171–177PubMedGoogle Scholar
  78. 78.
    Smith EM, Phan M, Kruger TE, Coppenhaver DH, Blalock JE (1982) Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci USA 80:6010–6013Google Scholar
  79. 79.
    Kruger TE, Blalock JE (1986) Cellular requirements for thyrotropin enhancement of in vitro antibody production. J Immunol 137:197–200PubMedGoogle Scholar
  80. 80.
    Kruger TE, Smith EM, Harbour DV, Blalock JE (1989) Thyrotropin: an endogenous regulator of the in vitro immune response. J Immunol 142:744–747PubMedGoogle Scholar
  81. 81.
    Bagriacik EU, Zhou Q, Wang H-C, Klein J (2001) Rapid and transient reduction in circulating thyroid hormones following systemic antigen priming: implications for functional collaboration between dendritic cells and thyroid. Cell Immunol 212:92–100PubMedGoogle Scholar
  82. 82.
    Klein JR, Wang H-C (2004) Characterization of a novel set of resident intrathyroidal bone marrow-derived hematopoietic cells: potential for immune-endocrine interactions in thyroid homeostasis. J Exp Biol 207:55–65PubMedGoogle Scholar
  83. 83.
    Wang H-C, Dragoo J, Zhou Q, Klein JR (2003) An intrinsic thyrotropin-mediated pathway of TNF-α production by bone marrow cells. Blood 101:119–123PubMedGoogle Scholar
  84. 84.
    Zhou Q, Wang H-C, Klein JR (2002) Characterization of a novel anti-mouse thyrotropin monoclonal antibody. Hybrid Hybridomics 21:75–79PubMedGoogle Scholar
  85. 85.
    Scofield VL, Montufar-Solis D, Cheng E, Estes MK, Klein JR (2005) Intestinal TSH production is localized in villus “hotblocks” and is coupled to IL-7 production: evidence for involvement of TSH during acute virus infection. Immunol Lett 99:36–44PubMedGoogle Scholar
  86. 86.
    Klein JR (2006) The immune system as a regulator of thyroid hormone activity. Exp Biol Med 231:229–236Google Scholar
  87. 87.
    Coutelier JP, Kehrl JH, Bellur SS, Kohn LD, Notkins AL, Prabhakar BS (1990) Binding and functional effects of thyroid stimulating hormone to human immune cells. J Clin Immunol 10:204–210PubMedGoogle Scholar
  88. 88.
    Bagriacik EU, Klein JR (2000) The thyrotropin (thyroid stimulating hormone) receptor is expressed on murine dendritic cells and on a subset of CD43RBhigh lymph node T cells: functional role of thyroid stimulating hormone during immune activation. J Immunol 164:6158–6165PubMedGoogle Scholar
  89. 89.
    Kruger TE (1996) Immunomodulation of peripheral lymphocytes by hormones of the hypothalamus-pituitary-thyroid axis. Adv Neuroimmunol 6:387–395PubMedGoogle Scholar
  90. 90.
    Fabris N, Mochegiani E, Provinciali M (1995) Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine-immune interaction. Horm Res 43:29–38PubMedGoogle Scholar
  91. 91.
    Provinciali M, Di Stefano G, Fabris N (1992) Improvement in the proliferative capacity and natural killer cell activity of murine spleen lymphocytes by thyrotropin. Int J Immunopharmacol 14:865–870PubMedGoogle Scholar
  92. 92.
    Migita K et al (1989) Cytotoxic activity of interleukin-2 (Il-2) activated killer cells toward thyroid epithelial cells. Clin Exp Immunol 77:196–201PubMedGoogle Scholar
  93. 93.
    Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM (1988) Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 318(24):1557–1563PubMedGoogle Scholar
  94. 94.
    Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ (2009) Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 160(6):985–991PubMedGoogle Scholar
  95. 95.
    Elizabeth N (2008) Association of first trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multi-vitamin use. Endocr Pract 14(1):33–39Google Scholar
  96. 96.
    Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Wallenstein S, Davies TF (1992) A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 74:645–653PubMedGoogle Scholar
  97. 97.
    Casey BM, Dashe JS, Wells CE et al (2005) Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105(2):239–245PubMedGoogle Scholar
  98. 98.
    Spencer C, Lee R, Kazarosyan M et al (2005) Thyroid reference ranges in pregnancy: studies on an iodine sufficient cohort. Thyroid 15(1):1–16Google Scholar
  99. 99.
    Glinoer D, Riahi M, Grün JP, Kinthaert J (1994) Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 79:197–204PubMedGoogle Scholar
  100. 100.
    Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O (2002) Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12:63–68PubMedGoogle Scholar
  101. 101.
    Negro R (2006) Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metabol 91(7):2587–2591Google Scholar
  102. 102.
    Amino N et al (1982) Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves’ disease and increase in Hashimoto’s disease. J Clin Endocrinol Metab 54:587–591PubMedGoogle Scholar
  103. 103.
    Sawada K, Saturami T, Imura H, Iwamori M, Nabai Y (1980) Anti-asialo-GMI antibody in sera from patients with Graves’ disease and Hashimoto’s thyroiditis [letter]. Lancet 2:198PubMedGoogle Scholar
  104. 104.
    Papic M, Stein-Streilein J, Zakarija M, McKenzie JM, Guffee J, Fletcher MA (1987) Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest 79:404–408PubMedGoogle Scholar
  105. 105.
    Wang PW, Luo SF, Huang BY, Lin JD, Huang MJ (1988) Depressed natural killer cell activity in Graves’ disease and during antithyroid medication. Clin Endocrinol 28:205–214Google Scholar
  106. 106.
    Marazuela M, Vargas JA, Alvarez-Mon M, Albarran F, Lucas T, Durantez A (1995) Impaired natural killer cell cytotoxicity in peripheral blood mononuclear cells in Graves’ disease. Eur J Endocrinol 132:175–180PubMedGoogle Scholar
  107. 107.
    Calder EA, Irvine WJ, Davidson NM, Wu FT (1976) B and K cells in autoimmune thyroid disease. Clin Exp Immunol 25:17–23PubMedGoogle Scholar
  108. 108.
    Tezuka H et al (1988) Natural killer and natural killer-like activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves’ disease. J Clin Endocrinol Metabol 66:702–707Google Scholar
  109. 109.
    Pedersen BK, Feldt-Rasmussen U, Bech K, Perrild H, Klarlund K, Hoier-Madsen M (1989) Characterization of the natural killer activity in Hashimoto’s and Graves’ diseases. Allergy 44:477–481PubMedGoogle Scholar
  110. 110.
    Pruzanski W, Capes H, Baur R, Wenzel BE, Row VV, Volpe R (1984) Biological activity of lymphocytotoxic antibodies in Graves’ disease and Hashimoto’s thyroiditis. J Endocrinol Invest 7:7–13PubMedGoogle Scholar
  111. 111.
    Hidaka Y et al (1992) Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Autoimmunity 11:239–246PubMedGoogle Scholar
  112. 112.
    Wenzel BE, Chow A, Baur R, Schleusener H, Wall JR (1998) Natural killer cell activity in patients with Graves’ disease and Hashimoto’s thyroiditis. Thyroid 8:1019–1022PubMedGoogle Scholar
  113. 113.
    Solerte SB (2005) Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur J Endocrinol 152:703–712PubMedGoogle Scholar
  114. 114.
    Solovera J, Alverez-Mon M, Casas J, Carballido J, Durantez A (1987) Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist. J Immunol 139:876–880PubMedGoogle Scholar
  115. 115.
    Weetman AP, Gunn C, Hall R, McGregor AM (1985) The absence of any effect of methimazole on in vitro cell-mediated cytotoxicity. Clin Endocrinol 22:57–64Google Scholar
  116. 116.
    Solerte SB, Cravello L, Ferrari E, Fioravanti M (2000) Overproduction of IFN-γ and TNF-α from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer’s disease. Ann NY Acad Sci 917:331–340PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Center for Reproductive HealthMedical University of PlevenPlevenBulgaria

Personalised recommendations